Home › Funds › Aptus Capital Advisors, LLC › IBDX

Aptus Capital Advisors, LLC position in IBDX

ISHARES TR

Aptus Capital Advisors, LLC reported holding 6,316,655 shares of IBDX (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$152.0M, representing 1.30% of its reported portfolio and ranking #13 among its reported holdings. Aptus Capital Advisors, LLC has disclosed IBDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.32M sh
Reported value held$152.04M
Portfolio Weight1.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aptus Capital Advisors, LLC's IBDX position evolved

Aptus Capital Advisors, LLC first disclosed a stake in IBDX in Q3 2023 at 1,397,819 shares (US$32.8M). The position peaked in Q2 2026 at 6,456,747 shares, worth US$162.6M. Across 13 filings, Aptus Capital Advisors, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,316,655 shares valued at US$152.0M — a reduction of -140,092 shares quarter over quarter.. Notable position changes include a 58% trim in Q4 2023 (shares fell 2% over the following quarter), a 97% increase in Q1 2024 (shares fell 1% over the following quarter), a 68% increase in Q4 2024 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.40M $32.82M New
Q4 2023 584.31K $14.74M Reduce
Q1 2024 1.15M $28.58M Add
Q2 2024 1.54M $37.75M Add
Q3 2024 2.12M $54.55M Add
Q4 2024 3.56M $87.50M Add
Q1 2025 4.00M $100.07M Add
Q2 2025 4.26M $107.75M Add
Q3 2025 4.61M $118.17M Add
Q4 2025 6.23M $159.03M Add
Q1 2026 6.34M $160.29M Add
Q2 2026 6.46M $162.65M Add
Q3 2026 6.32M $152.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBDX and 13F data

IBDX (ISHARES TR) is a company whose sector is not yet classified in our data. 35 other funds we track also report a position in IBDX — the largest reported positions include Capital Investment Advisors, LLC (US$88.2M), CAPITAL ADVISORS INC/OK (US$71.1M), SIGMA INVESTMENT COUNSELORS INC (US$36.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBDX

All IBDX fund holders →

FAQ

How long has Aptus Capital Advisors, LLC held IBDX?

Aptus Capital Advisors, LLC has disclosed IBDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aptus Capital Advisors, LLC's current position in IBDX?

As of Q3 2026, Aptus Capital Advisors, LLC holds 6.32M shares of IBDX (ISHARES TR), valued at $152.04M, representing 1.30% of its reported portfolio and ranking #13.

Has Aptus Capital Advisors, LLC been buying or selling IBDX?

In the latest 13F filing (Q3 2026), Aptus Capital Advisors, LLC reduced its position in IBDX. The position peaked in Q2 2026 at 6.46M shares.

Which other funds hold IBDX?

Other major institutional holders of IBDX include Capital Investment Advisors, LLC, CAPITAL ADVISORS INC/OK, SIGMA INVESTMENT COUNSELORS INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.